Oxcia

OxciaOxcia
Oxcia

Oxcia

AI-powered platform for automating complex business processes and workflows.

DR 252022Active12San Francisco, United States
Rate

About

Oxcia is a biotechnology company focused on managing cell health and DNA repair through its O2-DDR technology platform. This platform targets oxidative stress, oxidative DNA damage, and DNA Damage Response to potentially cure diseases and extend lives. Their lead clinical candidates, OXC-101 for cancer and OXC-201 for pulmonary fibrosis, are developed for patients with these conditions.
Frequently asked

What does Oxcia do?

Oxcia is a biotechnology company focused on managing cell health and DNA repair through its O2-DDR technology platform. This platform targets oxidative stress, oxidative DNA damage, and DNA Damage Response to potentially cure diseases and extend lives. Their lead clinical candidates, OXC-101 for cancer and OXC-201 for pulmonary fibrosis, are developed for patients with these conditions.

What is Oxcia's revenue?

StartupHub estimates Oxcia's annual revenue at $2.4M (range $1.4M to $2.7M, 62% confidence), based on comparable companies in the sector.

Where is Oxcia headquartered?

Oxcia is headquartered in San Francisco, United States.

When was Oxcia founded?

Oxcia was founded in 2022.

What industry does Oxcia operate in?

Oxcia operates in Agentic AI, AI Agent, Workflow Automation, Business Process Automation, Enterprise Software, API Platform.

How many employees does Oxcia have?

Oxcia has approximately 12 people on record.

HEADCOUNT
12
DOMAIN RATING
25
Comments

No comments yet. Be the first to share your take.